ASP Isotopes (ASPI) Expected to Announce Quarterly Earnings on Wednesday

ASP Isotopes (NASDAQ:ASPI - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Wednesday, May 21st. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $1.30 million for the quarter.

ASP Isotopes Stock Performance

NASDAQ:ASPI traded up $0.23 during mid-day trading on Monday, hitting $7.52. The stock had a trading volume of 4,446,738 shares, compared to its average volume of 2,426,786. The stock has a market capitalization of $564.47 million, a price-to-earnings ratio of -12.33 and a beta of 3.40. The company has a 50 day simple moving average of $5.28 and a 200-day simple moving average of $5.43. ASP Isotopes has a 52 week low of $1.86 and a 52 week high of $9.33. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80.

Insider Activity at ASP Isotopes

In related news, COO Robert Ainscow sold 66,666 shares of ASP Isotopes stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total value of $383,329.50. Following the sale, the chief operating officer now directly owns 1,553,326 shares in the company, valued at $8,931,624.50. This trade represents a 4.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Paul Elliot Mann sold 316,666 shares of ASP Isotopes stock in a transaction dated Thursday, April 17th. The shares were sold at an average price of $5.62, for a total transaction of $1,779,662.92. Following the completion of the sale, the chief executive officer now owns 7,315,454 shares in the company, valued at approximately $41,112,851.48. This represents a 4.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 766,667 shares of company stock worth $4,358,502 in the last ninety days. 21.40% of the stock is owned by insiders.

Institutional Trading of ASP Isotopes

A hedge fund recently raised its stake in ASP Isotopes stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 9.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,613 shares of the company's stock after buying an additional 2,709 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in ASP Isotopes were worth $148,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 16.80% of the company's stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.